Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV
Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV
Recruiting · NCT07726433 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Recruiting | Phase 2 | 2026-07-24 | NCT07726433 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Cancer Hospital Airport Hospital | Tianjin | China | 9 |